Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...
Due to continuing patient safety problems, ISMP suggests hospitals stop using insulin pens in an inpatient setting, as they were originally intended for ambulatory care. “Other problems such as using ...
With FDA clearance secured for its Bluetooth-connected insulin dose-tracking technology, Eli Lilly is ready to pick up the tempo. The Big Pharma plans to begin rolling out its Tempo diabetes ...
Sportschosun on MSN
Increased access to diabetes treatment...Huons slashes price of smart insulin pen Diacon P8 by 31%
Huons announced that it will cut the sales price of its smart insulin pen 'Diacon P8' by 31% compared to the previous price ...
(Reuters Health) - A warning for people who use insulin pens: Not shaking your NPH insulin pen before injecting can result in wide variations in your insulin level and blood sugar control, researchers ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin pens to $1 per device in low- and middle-income countries (LMICs). Pens are ...
As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities. “To address our current capacity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback